Anne M. Neilan

Infectious Disease

55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIV.

Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIV.

Journal: JAMA network open

Published: July 07, 2026

Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035.

Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035.

Journal: medRxiv : the preprint server for health sciences

Published: January 02, 2026

Long-Acting PrEP for People With High Vulnerability to HIV Acquisition in Brazil: A Cost-Effectiveness Analysis.

Long-Acting PrEP for People With High Vulnerability to HIV Acquisition in Brazil: A Cost-Effectiveness Analysis.

Journal: Journal of the International AIDS Society

Published: September 05, 2025

We must fill the void in global HIV care without PEPFAR.

We must fill the void in global HIV care without PEPFAR.

Journal: BMJ (Clinical research ed.)

Published: July 10, 2025

Ending the HIV Epidemic in the United States Among Men Who Have Sex With Men: A Modeling Analysis.

Ending the HIV Epidemic in the United States Among Men Who Have Sex With Men: A Modeling Analysis.

Journal: Open forum infectious diseases

Published: July 08, 2025

Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks.

Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks.

Journal: Annals of the American Thoracic Society

Published: July 08, 2025

Differences in Sexual Health Clinic Services by Age and Gender in Metropolitan Boston.

Differences in Sexual Health Clinic Services by Age and Gender in Metropolitan Boston.

Journal: Sexually transmitted diseases

Published: June 08, 2025

Cost-Effectiveness Analyses of Adolescent- and Young-Adult-Focused HIV Interventions Incorporating HIV Transmission: a Scoping Review of Modeling Methods and Proposed Guidance.

Cost-Effectiveness Analyses of Adolescent- and Young-Adult-Focused HIV Interventions Incorporating HIV Transmission: a Scoping Review of Modeling Methods and Proposed Guidance.

Journal: PharmacoEconomics - open

Published: May 11, 2025

Projecting lifetime HIV-related healthcare costs for youth with HIV in the United States.

Projecting lifetime HIV-related healthcare costs for youth with HIV in the United States.

Journal: BMC health services research

Published: April 16, 2025

The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.

The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.

Journal: The lancet. HIV

Published: March 27, 2025

Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness.

Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness.

Journal: The Journal of infectious diseases

Published: February 13, 2025

Potential Clinical and Economic Impacts of Cutbacks in the President's Emergency Plan for AIDS Relief Program in South Africa : A Modeling Analysis.

Potential Clinical and Economic Impacts of Cutbacks in the President's Emergency Plan for AIDS Relief Program in South Africa : A Modeling Analysis.

Journal: Annals of internal medicine

Published: February 11, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026